Non-proprietary names from 'gabapentin' to 'gamma-d-glutamyl-tryptophan' - Electronic medicinal guide TALKDRUGS

VI.G40-G47.G40.0   Localized (focal) (partial) idiopathic epilepsy and epileptic syndromes with convulsive seizures with a focal start

VI.G40-G47.G40.2   Localized (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

VI.G40-G47.G40.1   Localized (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

VI.G50-G59.G53.0 *   Neuralgia after shingles (B02.2 +)

XVIII.R90-R94.R93.3   The abnormalities detected in obtaining a diagnostic image during the examination of other parts of the digestive tract

XVIII.R90-R94.R93.2   Abnormalities detected in the diagnostic imaging of the liver and bile ducts

XVIII.R90-R94.R90.8   Other abnormalities detected in the diagnosis of the central nervous system

XVIII.R90-R94.R90   The abnormalities detected in obtaining diagnostic images during the examination of the central nervous system

XXI.Z00-Z13.Z03.5   Observation for suspected other cardiovascular disease

XXI.Z00-Z13.Z03.1   Observation for suspected malignant tumor

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XXI.Z00-Z13.Z03.8   Observation for suspected other diseases and conditions

XXI.Z00-Z13.Z03.1   Observation for suspected malignant tumor

XXI.Z00-Z13.Z03.1   Observation for suspected malignant tumor

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XX.Y40-Y59.Y57.6   Other diagnostic drugs

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

XX.Y40-Y59.Y57.6   Other diagnostic drugs

I.A80-A89.A80   Acute poliomyelitis

I.A80-A89.A84   Tick-borne viral encephalitis

I.B90-B94.B91   Consequences of poliomyelitis

V.F00-F09.F00 *   Dementia in Alzheimer's disease (G30 .- +)

VI.G00-G09.G04   Encephalitis, myelitis and encephalomyelitis

VI.G50-G59.G51   Lesions of the facial nerve

VI.G50-G59.G58.9   Mononeuropathy, unspecified

VI.G60-G64.G61.0   Guillain-Barre Syndrome

VI.G60-G64.G62   Other polyneuropathies

VI.G70-G73.G70   Myasthenia gravis and other disorders of the neuromuscular synapse

VI.G70-G73.G71.0   Muscular dystrophy

VI.G70-G73.G72   Other myopathies

VI.G80-G83.G80   Cerebral palsy

VI.G90-G99.G90.9   Disorder of autonomic nervous system, unspecified

XI.K94.K94 *   Diagnosis of diseases of the digestive tract

XIII.M50-M54.M54.1   Radiculopathy

XIII.M70-M79.M79.2   Neuralgia and neuritis, unspecified

XIV.N30-N39.N31.2   Neurogenic weakness of the bladder, not elsewhere classified

XIV.N30-N39.N39.4   Other specified incontinence

XIX.T08-T14.T14.4   Injury of nerve (nerves) of unspecified body region

XIX.T36-T50.T40   Poisoning and Drug psychodysleptics [hallucinogens]

XIX.T36-T50.T44   Poisoning by drugs, acting primarily on the autonomic nervous system

XX.Y40-Y59.Y57.6   Other diagnostic drugs

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

IX.I10-I15.I10   Essential [primary] hypertension

IX.I20-I25.I20   Angina pectoris [angina pectoris]

IX.I20-I25.I20.1   Angina with documented spasm

IX.I20-I25.I21   Acute myocardial infarction

IX.I30-I52.I47.1   Nadzheludochkovaya tachycardia

IX.I30-I52.I48   Atrial fibrillation and flutter

IX.I30-I52.I49.4   Other and unspecified depolarization

V.F20-F29.F20   Schizophrenia

V.F20-F29.F22.0   Delusional Disorder

V.F20-F29.F29   Inorganic psychosis, unspecified

V.F30-F39.F30   Manic episode

V.F40-F48.F45   Somatoform disorders

V.F60-F69.F60.2   Dissocial personality disorder

V.F70-F79.F79   Mental retardation, unspecified

V.F90-F98.F91   Behavioral disorders

V.F90-F98.F95.2   Combining vocalisms and multiple motor tics [de la Tourette's syndrome]

V.F90-F98.F98.5   Stuttering [stammering]

VI.G10-G13.G10   Huntington's disease

XVIII.R10-R19.R11   Nausea and vomiting

XVIII.R40-R46.R44.3   Other hallucinations

XX.Y83-Y84.Y83.9   Surgical operation, unspecified

IV.E70-E90.E76   Disorders of glycosaminoglycan metabolism

II.C81-C96.C84   Peripheral and cutaneous T-cell lymphomas

III.D55-D59.D59.1   Other autoimmune hemolytic anemia

III.D65-D69.D69.3   Idiopathic thrombocytopenic purpura

III.D70-D77.D70   Agranulocytosis

XII.L10-L14.L10   Pemphigus [pemphigus]

XII.L20-L30.L20.8   Other atopic dermatitis

XII.L20-L30.L28.0   Simple chronic lichen

XII.L40-L45.L40   Psoriasis

XIII.M05-M14.M05   Seropositive rheumatoid arthritis

XXI.Z20-Z29.Z29.8   Other specified preventive measures

XXI.Z80-Z99.Z94   Presence of transplanted organs and tissues